A false claim is circulating online that the European Medicines Agency (EMA) has acknowledged that mRNA vaccines have not ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Medicines Agency (EMA) has validated for parallel accelerated review the company’s ...

Ireland’s medicines approval system is no longer fit for purpose, but is the government committed to renewing it fairly?

Gilead (GILD) announced that the European Medicines Agency has validated for parallel accelerated review the company’s marketing authorization ...

One of the main challenges identified by the research was that, although the European Medicines Agency (EMA) approves new ...

Patients should have faster access to newly developed drugs and medicines and the Government is prepared to adopt new ...

Global biotechnology leader CSL (ASX: CSL; USOTC: CSLLY) and sa-mRNA pioneer Arcturus Therapeutics (Nasdaq: ARCT) today ...

India remains a preferred outsourcing destination, with a 30–35 per cent cost advantage over Western competitors. Emerging ...

Belgian MEP Liesbet Sommen spoke with Euractiv about critical medicines shortages, EU Pharma Package progress, and SANT's evolving role.

Foster City, California Tuesday, February 25, 2025, 16:00 Hrs [IST] ...